Skip to content

Validation of a Wearable Non-invasive Device (the Patch)

Validation of a Wearable Non-invasive Device (the Patch) to Aid in Diagnosing Sleep Apnea

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03816566
Enrollment
60
Registered
2019-01-25
Start date
2018-12-23
Completion date
2019-08-23
Last updated
2019-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea

Brief summary

BresoTEC has designed and developed a standalone wearable device (the patch), that can record tracheal sounds with a microphone attached just above the suprasternal notch of the subject.

Detailed description

The patch also has a 3-dimensional accelerometer to record body position. Furthermore, the patch records oxygen saturation using an FDA cleared pulse oximeter, Nonin 3150 WristOx2® with Bluetooth Low Energy. We have developed advanced signal processing algorithms to detect apneas and hypopneas. Many of these techniques for analyzing breathing sounds and detecting apneas and hypopneas have been published in peer-reviewed journals. The goal of this study is to validate the patch against polysomnography (PSG) for use as an aid in the diagnosis of sleep apnea for adult patients. Our primary objective is to assess whether the estimated apnea-hypopnea index (AHI) calculated by the patch agrees with the results of an in-laboratory PSG.

Interventions

DEVICEpatch

A standalone wearable device (the patch), that can record tracheal sounds with a microphone attached just above the suprasternal notch of the subject. The patch also has a 3-dimensional accelerometer to record body position. Furthermore, the patch records oxygen saturation using an FDA cleared pulse oximeter, Nonin 3150 WristOx2® with Bluetooth Low Energy.

Sponsors

BresoTEC Inc.
Lead SponsorINDUSTRY

Study design

Intervention model
SEQUENTIAL
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

The outcome assessor performing the automatic analysis of the patch data will be blinded to the PSG scores performed by the Sleep Lab Technicians. The principal investigator responsible for the completion and closing of the study according to the protocol will be blinded to the patch AHI automatic analysis. Similarly, the Sleep Lab Technicians scoring the PSG will be blinded to the patch automatic analysis. By the end of recruiting the target sample size, the data will be un-blinded and statistical analysis will be performed.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inclusion criteria are men and women 18 years and above, who are referred to either the University Health Network (UHN), Toronto Rehabilitation Institute (TRI) or Toronto General Hospital sleep laboratories for overnight PSG because of a suspicion of a sleep disorder. It is intended for the general outpatient population.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Estimation of AHI8 monthsValidate the performance of the patch in estimating the AHI compared to an in-laboratory PSG.

Secondary

MeasureTime frameDescription
Estimation of body position8 monthsValidate the performance of the patch in estimating body position during sleep compared to an in-laboratory PSG.

Countries

Canada

Contacts

Primary ContactHisham Alshaer, MD, PhD
Hisham.Alshaer@uhn.ca416-597-3422

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026